Fir Tree Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-260,000
Closed -$49.7M 95
2019
Q4
$49.7M Sell
260,000
-287,800
-53% -$51.9M 4.9% 10
2019
Q3
$92.2M Buy
547,800
+287,800
+111% +$46.9M 8.99% 2
2019
Q2
$43.5M Buy
+260,000
New +$36M 4.36% 7
2016
Q3
Sell
-279,169
Closed -$64.5M 66
2016
Q2
$64.5M Sell
279,169
-217,825
-44% -$50.2M 2.64% 13
2016
Q1
$133M Sell
496,994
-626,561
-56% -$179M 5.04% 8
2015
Q4
$351M Sell
1,123,555
-314,474
-22% -$93.6M 6.23% 2
2015
Q3
$391M Sell
1,438,029
-61,950
-4% -$19M 6.55% 3
2015
Q2
$455M Buy
1,499,979
+191,188
+15% +$57M 7.25% 2
2015
Q1
$390M Buy
1,308,791
+215,758
+20% +$61.5M 5.56% 3
2014
Q4
$281M Buy
+1,093,033
New +$273M 2.93% 10

Other funds holding AGN

Fir Tree Capital Management's AGN Position: Q1 2020 in Review

Fir Tree Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 260,000 shares — an estimated $49.7M sold.

Fir Tree Capital Management first reported a position in AGN in Q4 2014 and held it in 10 quarters. The position peaked at $455M in Q2 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Fir Tree Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Fir Tree Capital Management sold 260,000 Allergan plc shares in Q1 2020, an estimated $49.7M.
  • Fir Tree Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 10 quarters.
  • Fir Tree Capital Management's Allergan plc position peaked at $455M in Q2 2015.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Fir Tree Capital Management's 13F filing for Q1 2020, filed 15 May 2020.